Isofistularin-3 is a direct DNA-competitive DNMT1 inhibitor (IC50 = 13.5 μM) and functions as a DNA demethylating agent; it induces tumor cell cycle arrest in the G0/G1 phase and sensitizes cancer cells to TRAIL-induced apoptosis; it can be used as the cytotoxic payload in antibody-drug conjugates (ADCs); it inhibits proliferation of a broad panel of cancer cell lines (GI50 = 7.3–14.8 μM); it induces morphological changes, autophagy, and both caspase-dependent and -independent cell death in RAJI cells; it promotes AHR promoter demethylation and upregulates AHR expression.